ClinicalTrials.Veeva

Menu

Signia Stapler Versus Vessel Sealer Extend Energy Device With SureForm Stapling in Robotic-Assisted Segmentectomy

S

St. Joseph's Healthcare Hamilton

Status

Completed

Conditions

Lung Cancer
Lung Neoplasm
Thoracic Cancer

Treatments

Drug: Da Vinci Vessel Sealer Extend Energy Device with SureForm Stapling
Device: Medtronic Signia Stapler

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Robotic-assisted thoracoscopic surgery (RTS) segmentectomy is safe and effective for patients with early-stage non-small cell lung cancer (NSCLC). In RTS-segmentectomy, dissection and sealing procedures are performed by either staplers or energy devices.

Staplers, the current standard of care, have been associated with higher operating costs compared to energy devices for open lobectomy, RTS lobectomy and minimally invasive segmentectomy. However, there is a lack of prospective research evaluating the costs of the two methods for lung dissection and vessel sealing in RTS-segmentectomy.

This prospective trial seeks to determine whether it is feasible to conduct a randomized controlled trial evaluating the costs of the Signia stapler versus Vessel Sealer Extend energy device in RTS-segmentectomy for NSCLC. If this trial is feasible, we will be able to conduct a full-scale trial to compare costs and health outcomes, providing an economic evaluation that will inform hospital decision makers and clinicians in Canada.

Enrollment

56 patients

Sex

All

Ages

18 to 120 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 18 and 120 years at time of consent
  • Ability to speak and understand English
  • Clinical stage I, II or IIIa NSCLC
  • Candidate for RTS segmentectomy, as determined by the operating surgeon

Exclusion criteria

  • Anticoagulation with inability to cease anticoagulant therapy prior to surgery
  • Incurable coagulopathy
  • Systemic vascular disease or vasculitis
  • Not a candidate for RTS segmentectomy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

56 participants in 2 patient groups

Medtronic Signia Stapler
Active Comparator group
Description:
Patients randomized to this arm will undergo RTS segmentectomy with the Medtronic Signia Stapler.
Treatment:
Device: Medtronic Signia Stapler
Da Vinci Vessel Sealer Extend Energy Device with SureForm Stapling
Experimental group
Description:
Patients randomized to this arm will undergo RTS segmentectomy with the Da Vinci Vessel Sealer Extend Energy Device with SureForm Stapling.
Treatment:
Drug: Da Vinci Vessel Sealer Extend Energy Device with SureForm Stapling

Trial contacts and locations

1

Loading...

Central trial contact

Yogita S Patel, BSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems